Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2003);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;21191;Pharmacological Reviews;journal;15210081, 00316997;13.345;Q1;241;29;68;7430;2160;67;27.62;256.21;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
2;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.847;Q1;210;25;83;3063;1864;82;23.11;122.52;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;6.281;Q1;348;260;232;7253;1353;87;5.83;27.9;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;3.83;Q1;225;133;500;5424;3150;382;5.79;40.78;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
5;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.119;Q1;211;62;196;12447;1524;193;7.67;200.76;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
6;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.11;Q1;190;165;391;5931;2206;369;5.45;35.95;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.001;Q1;233;236;561;20896;3034;545;5.25;88.54;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;2.919;Q1;66;20;19;4722;108;19;6.67;236.1;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
9;82448;Mutation Research - DNA Repair;journal;09218777;2.758;Q1;75;0;154;0;757;152;4.15;0;Netherlands;Western Europe;Elsevier BV;1989-2001;"Genetics (Q1); Molecular Biology (Q1); Toxicology (Q1)"
10;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.724;Q1;202;339;1029;12981;5994;1027;5.71;38.29;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
11;26371;Natural Product Reports;journal;02650568, 14604752;2.71;Q1;188;43;115;6706;741;113;6.77;155.95;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
12;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.603;Q1;134;29;76;4077;597;76;8.13;140.59;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.486;Q1;227;274;538;14161;2993;505;5.09;51.68;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
14;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.224;Q1;115;67;167;4199;758;165;4.72;62.67;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Cell Biology (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
15;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.208;Q1;269;710;2041;19690;10065;1960;4.8;27.73;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
16;18148;Pain;journal;18726623, 03043959;2.195;Q1;269;307;738;12357;3869;673;4.81;40.25;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
17;12455;Molecular Therapy;journal;15250024, 15250016;2.122;Q1;185;248;611;7857;3168;520;4.95;31.68;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;2.116;-;144;99;282;3093;1690;273;6.05;31.24;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
19;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;1.934;Q1;331;101;376;9929;2269;334;6.53;98.31;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
20;20435;Neuropharmacology;journal;00283908, 18737064;1.83;Q1;176;219;760;10316;3055;760;3.83;47.11;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
21;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.771;Q1;276;619;1637;25291;7909;1580;4.53;40.86;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
22;21782;Psychopharmacology;journal;00333158, 14322072;1.743;Q1;202;325;973;15797;3711;929;3.64;48.61;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
23;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.708;Q1;129;109;329;3721;911;317;2.4;34.14;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
24;26795;Controlled Clinical Trials;journal;01972456;1.696;Q1;74;70;214;1616;474;178;1.75;23.09;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
25;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.693;Q1;89;18;23;2152;137;22;3.43;119.56;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
26;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.682;Q1;233;610;1808;22972;8351;1807;4.63;37.66;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
27;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.629;Q1;90;55;119;1899;369;105;3.1;34.53;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
28;23010;Journal of Controlled Release;journal;18734995, 01683659;1.61;Q1;282;270;729;8094;2820;724;3.55;29.98;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
29;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;1.606;Q1;139;108;199;5208;818;182;4.11;48.22;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
30;15984;Journal of Molecular Medicine;journal;09462716, 14321440;1.6;Q1;146;98;321;4851;1144;289;3.4;49.5;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
31;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.567;Q1;183;194;341;21208;1640;319;4.35;109.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
32;23916;Environmental Pollution;journal;02697491, 18736424;1.562;Q1;249;281;764;10366;1935;743;2.29;36.89;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
33;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.511;Q1;182;212;706;6722;2777;699;3.95;31.71;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
34;12611;Drug Resistance Updates;journal;13687646, 15322084;1.502;Q1;119;33;114;2929;467;106;5.09;88.76;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;21790;Antiviral Therapy;journal;20402058, 13596535;1.484;Q1;89;81;122;2616;420;112;3.19;32.3;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
36;26512;Tetrahedron;journal;14645416, 00404020;1.482;Q1;226;1067;3320;43083;9116;3304;2.78;40.38;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
37;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.474;Q1;223;533;1864;21798;6786;1844;3.54;40.9;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
38;26380;Drug and Alcohol Dependence;journal;03768716;1.439;Q1;173;155;391;6433;1338;381;3.06;41.5;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
39;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.431;Q1;163;191;559;8453;2080;556;3.6;44.26;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
40;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.427;Q1;206;481;1210;20367;4292;1182;3.02;42.34;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
41;68602;Immunopharmacology;journal;01623109;1.418;Q1;68;0;113;0;491;110;0;0;Netherlands;Western Europe;Elsevier BV;1978-2000;Pharmacology (Q1)
42;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.39;Q1;177;168;430;5729;1638;427;3.78;34.1;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
43;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.372;Q1;166;249;431;24398;1992;370;5.13;97.98;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
44;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.367;Q1;203;472;1223;11283;3924;969;3;23.9;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
45;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.359;Q1;115;132;404;4990;882;403;2;37.8;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
46;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.343;Q1;120;164;136;7816;243;94;1.79;47.66;United States;Northern America;Landes Bioscience;2002-2021;"Cancer Research (Q1); Oncology (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
47;20663;Current Drug Metabolism;journal;18755453, 13892002;1.339;Q1;111;38;87;4033;382;82;4.28;106.13;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
48;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.316;Q1;169;82;236;7970;1234;228;4.61;97.2;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
49;26514;Tetrahedron Letters;journal;00404039, 18733581;1.312;Q1;173;2091;6755;52456;16288;6753;2.47;25.09;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
50;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.303;Q1;72;60;138;1535;389;138;2.63;25.58;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Immunology (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Microbiology (medical) (Q1); Pharmacology (Q1)"
51;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.302;Q1;76;41;187;2066;497;183;2.81;50.39;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Physiology (Q1); Biochemistry (Q2); Cell Biology (Q2)"
52;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.276;Q1;122;101;122;9968;530;122;4.34;98.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
53;20664;Current Drug Targets;journal;18735592, 13894501;1.255;Q1;107;62;90;6207;304;83;3.07;100.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
54;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.238;Q1;94;110;185;4356;744;181;3.77;39.6;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
55;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.2;Q1;159;275;863;11388;2411;854;2.58;41.41;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
56;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.17;Q1;213;275;762;7452;2215;752;2.69;27.1;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
57;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.164;Q1;76;13;45;1928;155;44;3.45;148.31;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
58;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.144;Q1;175;207;638;9431;2059;623;3.09;45.56;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
59;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.141;Q1;168;109;246;2583;600;245;1.73;23.7;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
60;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.127;Q1;113;58;144;2265;419;133;2.97;39.05;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
61;23053;Journal of Natural Products;journal;01633864, 15206025;1.123;Q1;147;370;1258;7497;2664;1254;2.08;20.26;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
62;25218;Toxicological Sciences;journal;10960929, 10966080;1.116;Q1;193;277;802;11064;2551;775;2.97;39.94;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
63;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.112;Q1;97;40;121;1227;409;108;4.07;30.68;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
64;19427;Advances in Pharmacology;journal;15578925, 10543589;1.111;Q1;78;0;29;0;84;27;0;0;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
65;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;1.104;Q1;195;140;807;3952;2464;744;2.42;28.23;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
66;22072;Current Gene Therapy;journal;18755631, 15665232;1.104;Q1;75;40;58;4126;234;58;4.03;103.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
67;29311;Current Cancer Drug Targets;journal;15680096, 18735576;1.097;Q1;96;39;36;3957;140;36;3.89;101.46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1); Cancer Research (Q2)"
68;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.09;Q1;83;71;202;3022;458;189;1.99;42.56;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
69;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.09;Q1;78;100;341;1905;667;318;1.84;19.05;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
70;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.08;Q1;140;219;496;8226;1666;408;2.95;37.56;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
71;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.072;Q1;139;259;913;11935;2189;907;2.42;46.08;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
72;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.07;Q1;70;52;131;2046;363;125;2.65;39.35;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
73;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.068;Q1;117;20;64;2954;239;64;2.54;147.7;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
74;24763;Addictive Behaviors;journal;03064603;1.062;Q1;135;138;252;4316;505;251;1.87;31.28;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
75;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;1.05;Q1;85;335;878;11462;1729;876;1.96;34.21;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q1); Inorganic Chemistry (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
76;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.029;Q1;96;44;172;1601;323;172;1.28;36.39;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
77;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.024;Q1;66;101;252;4049;722;232;2.93;40.09;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
78;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.017;Q1;121;74;186;2578;490;173;2.1;34.84;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
79;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.007;Q1;186;245;629;8003;1548;624;2.33;32.67;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
80;21165;PharmacoEconomics;journal;11707690, 11792027;1.006;Q1;104;103;328;4348;866;317;2.53;42.21;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
81;19617;Antiviral Research;journal;01663542, 18729096;0.995;Q1;134;95;230;4546;758;230;3.37;47.85;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
82;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.99;Q1;104;63;198;2607;606;198;2.37;41.38;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
83;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.984;Q1;93;156;479;5878;1208;477;2.01;37.68;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
84;21237;Drug Safety;journal;01145916, 11791942;0.981;Q1;131;82;257;5422;1068;252;3.66;66.12;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
85;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;0.981;Q1;229;396;1211;9238;2419;1202;1.85;23.33;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
86;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.979;Q1;144;133;363;3924;994;345;2.32;29.5;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
87;12584;Drug Metabolism Reviews;journal;10979883, 03602532;0.975;Q1;100;20;77;1644;266;75;3.49;82.2;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
88;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;0.973;Q1;95;34;177;1404;304;176;1.39;41.29;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
89;21333;European Journal of Pharmacology;journal;00142999, 18790712;0.971;Q1;189;759;2506;31129;6498;2501;2.49;41.01;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
90;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;0.971;Q1;109;153;769;13274;2281;745;2.99;86.76;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.946;Q1;102;151;404;3884;718;398;1.68;25.72;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
92;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;0.926;Q1;118;88;229;3082;558;224;2.35;35.02;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Biological Psychiatry (Q3)"
93;25075;Ecotoxicology;journal;09639292, 15733017;0.921;Q1;97;49;118;2197;216;110;1.51;44.84;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
94;21167;Pharmacogenomics;journal;14622416, 17448042;0.921;Q1;94;95;159;3303;449;145;2.46;34.77;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Genetics (Q3)"
95;37409;Anti-Cancer Drug Design;journal;02669536;0.917;Q1;53;0;81;0;262;81;2.03;0;United States;Northern America;Cognizant Communication Corporation;1985-2001;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Drug Discovery (Q1); Oncology (Q1); Pharmacology (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
96;22477;Investigational New Drugs;journal;01676997, 15730646;0.907;Q1;90;46;130;1813;336;127;2.37;39.41;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
97;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.906;Q1;100;41;57;4139;140;55;2.46;100.95;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
98;14805;Steroids;journal;0039128X, 18785867;0.906;Q1;107;134;351;5085;974;348;2.46;37.95;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
99;29682;Receptors and Channels;journal;10606823;0.887;Q1;42;40;71;2478;131;67;2;61.95;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q1); Pharmacology (Q1); Endocrinology (Q2); Cell Biology (Q3)"
100;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.883;Q1;171;536;1074;17122;2343;1073;2.26;31.94;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
101;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.881;Q1;114;146;482;4482;1183;480;2.29;30.7;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
102;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.872;Q1;36;8;25;1155;61;16;2.42;144.38;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
103;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.87;Q1;103;93;300;2942;660;282;2.07;31.63;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
104;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;0.869;Q1;91;116;176;9049;506;167;2.88;78.01;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Pharmacology (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
105;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.865;Q1;154;925;2189;20040;4751;2187;2.26;21.66;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
106;22432;International Immunopharmacology;journal;18781705, 15675769;0.856;Q1;119;184;374;7210;907;370;2.43;39.18;Netherlands;Western Europe;Elsevier;2001-2021;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
107;21744;Planta Medica;journal;14390221, 00320943;0.853;Q1;122;272;738;4925;1309;735;1.62;18.11;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
108;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.84;Q1;205;257;668;6346;1173;662;1.52;24.69;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Pharmacology (Q1); Drug Discovery (Q2)"
109;25219;Toxicology;journal;0300483X, 18793185;0.825;Q1;165;244;794;10841;1986;776;2.19;44.43;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
110;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0.819;Q1;153;205;577;5667;1503;511;2.62;27.64;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
111;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.812;Q1;104;280;865;8842;1762;856;2.09;31.58;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
112;25240;Toxicology Letters;journal;03784274, 18793169;0.806;Q1;150;269;661;9217;1622;648;2.35;34.26;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
113;22319;Toxicon;journal;18793150, 00410101;0.806;Q1;133;243;577;8124;1171;566;2.14;33.43;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q1)
114;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.799;Q2;79;68;147;1404;373;139;2.47;20.65;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
115;36497;Pharmaceutica Acta Helvetiae;journal;00316865;0.785;Q1;40;0;49;0;137;47;0;0;Netherlands;Western Europe;Elsevier BV;1945-2000;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
116;16948;Chirality;journal;1520636X, 08990042;0.784;Q2;80;135;357;3989;615;352;1.62;29.55;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
117;61687;Antiviral Chemistry and Chemotherapy, Supplement;journal;13502816;0.778;Q2;11;0;17;0;57;17;3.35;0;Switzerland;Western Europe;World Health Organization;1993-1995, 1997, 2001;"Pharmacology (Q2); Virology (Q2)"
118;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.776;Q1;95;62;160;2032;338;155;1.95;32.77;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
119;110172;Progress in Drug Research;book series;0071786X;0.776;Q1;44;25;48;3042;119;43;1.94;121.68;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
120;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.771;Q2;90;52;144;1790;231;143;1.56;34.42;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
121;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.768;Q1;32;11;28;223;79;25;2.93;20.27;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
122;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.755;Q2;80;66;185;1726;469;175;2.42;26.15;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
123;24652;Chemico-Biological Interactions;journal;00092797;0.753;Q2;128;131;450;4541;882;444;1.67;34.66;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
124;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.738;Q1;133;450;1120;9945;1987;1116;1.64;22.1;Netherlands;Western Europe;Elsevier;1983-2022;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
125;20473;Life Sciences;journal;18790631, 00243205;0.738;Q1;174;576;1731;20951;3839;1731;2.13;36.37;United States;Northern America;Elsevier Inc.;1962-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
126;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.734;Q2;63;95;189;2887;371;172;1.93;30.39;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
127;4000150314;Chemical Biology and Drug Design;journal;17470277;0.734;-;82;64;283;2109;484;278;1.66;32.95;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
128;55157;Perspectives in Drug Discovery and Design;journal;15739023, 09282866;0.73;Q2;38;0;33;0;93;31;0;0;Netherlands;Western Europe;Kluwer Academic Publishers;1993-2000;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
129;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.723;Q1;88;39;78;4027;189;74;2.33;103.26;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
130;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.717;Q2;96;109;357;2652;923;343;2.63;24.33;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
131;15840;Journal of Antibiotics;journal;00218820, 18811469;0.716;Q2;84;146;493;2236;636;395;1.13;15.32;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
132;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.713;Q1;66;77;135;2352;332;131;2.63;30.55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
133;18073;NeuroToxicology;journal;18729711, 0161813X;0.713;Q2;122;84;263;3426;555;262;1.74;40.79;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
134;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.712;Q2;103;58;237;3622;464;222;1.93;62.45;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Developmental Neuroscience (Q3); Cellular and Molecular Neuroscience (Q4)"
135;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.707;Q2;121;138;498;4346;1182;487;2.26;31.49;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
136;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.705;Q2;107;153;581;5451;1111;578;1.86;35.63;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
137;20677;Current Opinion in Drug Discovery and Development;journal;13676733;0.7;Q2;81;94;252;4970;554;238;2.34;52.87;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
138;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.699;Q2;90;39;43;5178;82;43;1.91;132.77;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
139;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;0.697;Q2;134;148;392;8355;771;388;2.11;56.45;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q2); Biological Psychiatry (Q3)"
140;18966;Mutagenesis;journal;02678357, 14643804;0.696;Q2;95;79;236;3218;425;230;1.78;40.73;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
141;14822;Xenobiotica;journal;00498254, 13665928;0.689;Q2;82;92;238;2765;547;236;2.33;30.05;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
142;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.688;Q2;183;188;463;7121;981;451;2.07;37.88;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
143;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.687;Q2;175;123;285;3662;600;281;1.89;29.77;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
144;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.679;Q2;62;45;125;1912;249;124;1.69;42.49;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
145;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.679;Q2;78;47;165;1229;303;163;1.9;26.15;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
146;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.674;Q2;64;21;54;473;80;51;1.48;22.52;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
147;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.668;Q2;55;33;57;3759;119;55;2.09;113.91;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
148;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.66;Q2;66;76;175;3924;416;160;2.51;51.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Medicine (miscellaneous) (Q1); Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
149;24604;Archives of Toxicology;journal;14320738, 03405761;0.655;Q2;121;98;323;3272;597;321;1.69;33.39;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
150;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.651;Q2;114;156;463;4240;1043;430;1.96;27.18;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
151;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.65;Q2;92;144;412;5208;693;406;1.74;36.17;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
152;20104;CNS Drug Reviews;journal;1080563X, 15273458;0.648;Q2;61;22;73;1957;149;73;2.62;88.95;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q2); Pharmacology (Q2)"
153;23942;Biomedical Chromatography;journal;10990801, 02693879;0.647;Q2;68;79;257;1869;353;255;1.34;23.66;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
154;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.646;Q1;36;9;60;297;113;59;0.92;33;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
155;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.642;Q2;96;131;391;4304;815;389;2.19;32.85;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
156;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.636;Q2;52;45;120;1937;163;108;1.51;43.04;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
157;23412;Journal of AOAC International;journal;10603271;0.634;Q2;90;168;642;2909;803;640;1.15;17.32;United States;Northern America;AOAC International;1993-2021;"Food Science (Q1); Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Pharmacology (Q2)"
158;24785;Alcohol;journal;07418329;0.633;Q2;83;69;246;2563;444;241;1.7;37.14;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2); Behavioral Neuroscience (Q3); Biochemistry (Q3); Neurology (Q3)"
159;21196;Drug Discovery Today;journal;18785832, 13596446;0.628;Q2;185;262;813;5113;1518;642;1.85;19.52;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
160;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.625;Q2;95;326;1099;6103;1304;1099;1.21;18.72;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Medicine (miscellaneous) (Q1); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2)"
161;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.624;Q2;113;141;392;5248;611;386;1.57;37.22;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3); Physiology (Q3)"
162;25093;Environmental Toxicology;journal;15227278, 15204081;0.623;Q2;81;50;216;1964;251;211;1.31;39.28;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
163;25864;Heterocycles;journal;03855414;0.623;Q2;66;367;1076;9284;1241;1070;1.26;25.3;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
164;22410;Inflammation Research;journal;1420908X, 10233830;0.622;Q2;94;123;445;3127;691;440;1.47;25.42;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
165;21687;American Journal of PharmacoGenomics;journal;11752203;0.619;Q2;38;39;55;3462;118;55;2.15;88.77;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
166;16836;BMC Chemical Biology;journal;14726769;0.614;Q2;20;1;5;13;8;5;1.6;13;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
167;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.613;Q2;64;32;108;1372;191;106;1.64;42.88;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
168;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.612;Q2;81;92;214;3469;375;214;1.77;37.71;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3)"
169;81781;Pharmaceutical Science and Technology Today;journal;14615347;0.61;Q1;54;0;86;0;143;81;0;0;Netherlands;Western Europe;Elsevier BV;1998-2000;Pharmaceutical Science (Q1)
170;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.609;Q1;62;47;174;892;177;170;0.84;18.98;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
171;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.608;Q2;112;69;212;2518;361;206;1.56;36.49;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
172;24028;Reproductive Toxicology;journal;08906238, 18731708;0.598;Q2;117;77;190;2723;375;176;1.96;35.36;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
173;25898;Journal of Peptide Science;journal;10752617, 10991387;0.584;Q2;68;74;195;3189;314;191;1.41;43.09;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
174;21186;Drug Design and Discovery;journal;10559612, 10292322;0.582;Q2;20;12;38;466;45;33;1;38.83;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q2); Molecular Medicine (Q3)"
175;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;0.579;Q2;79;178;271;9705;544;254;2.01;54.52;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
176;16533;Phytochemical Analysis;journal;09580344, 10991565;0.571;Q2;76;59;179;1188;222;179;1.39;20.14;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Food Science (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
177;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.569;Q1;73;34;149;802;236;140;1.62;23.59;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
178;25109;Inhalation Toxicology;journal;08958378, 10917691;0.567;Q2;90;78;319;2849;430;312;1.49;36.53;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
179;22378;Vascular Pharmacology;journal;18793649, 15371891;0.567;Q2;100;34;184;1129;248;178;1.2;33.21;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Molecular Medicine (Q3); Physiology (Q3)"
180;36479;International Journal of Immunopharmacology;journal;01920561;0.563;Q2;50;0;106;0;182;103;0;0;Netherlands;Western Europe;Elsevier BV;1979-2000;"Pharmacology (Q2); Immunology (Q3)"
181;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.559;Q2;87;137;429;6034;625;428;1.42;44.04;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
182;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.559;Q2;71;57;235;2692;302;196;1.23;47.23;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
183;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;0.556;Q2;94;61;145;6058;209;142;1.67;99.31;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
184;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.55;Q1;81;32;68;1235;145;66;1.57;38.59;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
185;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.55;Q2;95;74;89;5792;169;89;1.9;78.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
186;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.544;Q2;58;66;12;1349;22;11;1.83;20.44;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
187;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.544;Q2;67;149;438;1859;525;415;1.05;12.48;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
188;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.541;Q2;83;204;417;13857;817;403;1.89;67.93;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
189;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.532;Q2;54;34;110;1342;194;110;1.64;39.47;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Drug Discovery (Q3); Virology (Q3)"
190;25224;Toxicology in Vitro;journal;18793177, 08872333;0.532;Q2;112;101;251;3280;455;249;1.81;32.48;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
191;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.528;Q2;63;84;188;1233;365;163;2.02;14.68;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
192;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.528;Q1;81;58;210;1276;230;208;1.03;22;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
193;21169;Pharmacological Research;journal;10436618, 10961186;0.528;Q2;147;163;488;6120;790;487;1.57;37.55;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
194;17067;Phytomedicine;journal;09447113, 1618095X;0.525;Q1;127;112;277;3364;449;268;1.32;30.04;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
195;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.523;Q3;50;36;122;1147;250;122;2.04;31.86;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q1); Bioengineering (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
196;25214;Toxicologic Pathology;journal;15331601, 01926233;0.521;Q2;112;118;328;4373;493;313;1.49;37.06;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q4)"
197;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.52;Q2;47;22;135;1715;220;133;1.3;77.95;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2)"
198;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.518;Q2;76;72;187;1868;287;174;1.3;25.94;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
199;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.508;Q2;64;115;235;3635;284;232;1.04;31.61;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
200;16573;Phytotherapy Research;journal;10991573, 0951418X;0.5;Q2;140;257;480;6321;633;479;1.02;24.6;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
201;20051;BioDrugs;journal;11738804, 1179190X;0.499;Q2;71;55;198;3338;360;187;2.72;60.69;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
202;20027;BMC Pharmacology;journal;14712210;0.499;Q2;44;16;34;507;43;34;1.26;31.69;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
203;20770;Drug Delivery;journal;10717544, 15210464;0.498;Q1;72;38;94;872;134;94;1.16;22.95;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
204;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.497;Q1;61;43;123;1135;204;122;1.93;26.4;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
205;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.495;Q3;74;80;179;2412;237;179;1.07;30.15;United States;Northern America;Wiley-Blackwell;1986-2021;"Medicine (miscellaneous) (Q1); Process Chemistry and Technology (Q1); Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
206;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.493;Q1;52;62;186;1673;148;186;0.61;26.98;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q1)
207;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.485;Q2;90;115;435;2603;402;432;0.93;22.63;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Pharmacology (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
208;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.479;Q2;69;88;272;1872;396;257;1.01;21.27;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
209;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.478;Q3;66;43;103;1176;116;100;1.33;27.35;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Biology (Q4)"
210;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.478;Q2;50;24;76;1324;143;76;2.52;55.17;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
211;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.474;Q2;64;58;174;1677;268;174;1.43;28.91;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
212;13671;Biologicals;journal;10958320, 10451056;0.473;Q2;60;44;106;925;135;104;1.27;21.02;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Immunology and Microbiology (miscellaneous)  (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Bioengineering (Q3)"
213;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.472;Q1;122;363;988;9063;1208;978;1.26;24.97;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
214;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.471;Q2;17;1;27;209;34;27;0.6;209;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q2)
215;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.465;Q2;62;61;197;2388;201;191;0.89;39.15;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
216;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.464;Q2;52;56;100;883;56;96;0.58;15.77;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
217;25189;Reviews in Toxicology;journal;13826980;0.464;Q2;20;0;5;0;4;5;0.8;0;Netherlands;Western Europe;IOS Press BV;1997-1999, 2001;Toxicology (Q2)
218;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.462;Q2;39;30;117;1026;98;114;0.79;34.2;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
219;18077;Fitoterapia;journal;0367326X, 18736971;0.461;Q2;110;143;520;2097;468;520;0.82;14.66;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
220;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.453;Q2;77;125;408;7681;547;404;1.44;61.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
221;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.452;Q2;99;410;1308;5050;993;589;0.72;12.32;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
222;21194;Pharmacology;journal;00317012, 14230313;0.436;Q2;60;90;232;2715;338;227;1.05;30.17;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
223;21265;Drugs of the Future;journal;03778282;0.435;Q2;45;93;256;4750;329;256;1.3;51.08;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
224;24749;Addiction Biology;journal;13556215, 13691600;0.434;Q2;83;51;138;1926;163;136;1.39;37.76;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
225;19900192900;Molecular Informatics;journal;18681751, 18681743;0.431;Q3;70;72;89;2371;150;87;1.65;32.93;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Structural Biology (Q3); Molecular Medicine (Q4)"
226;27210;In Vivo;journal;17917549, 0258851X;0.43;Q2;64;104;280;3547;310;277;0.83;34.11;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
227;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.427;Q2;124;205;886;6816;1063;881;1.74;33.25;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
228;21192;Drug Development Research;journal;02724391, 10982299;0.426;Q3;62;141;343;6354;397;335;1.15;45.06;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
229;33349;Japanese Journal of Pharmacology;journal;13473506, 00215198;0.425;Q2;62;0;554;0;789;551;1.43;0;Japan;Asiatic Region;Japanese Pharmacological Society;1951-2002;Pharmacology (Q2)
230;24578;Mathematical Medicine and Biology;journal;14778599;0.424;Q2;46;16;55;526;49;55;0.88;32.88;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Modeling and Simulation (Q3); Neuroscience (miscellaneous) (Q3)"
231;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.423;Q2;51;240;687;4644;550;684;0.77;19.35;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
232;16067;Reading Teacher;journal;00340561;0.423;Q2;53;93;213;1745;104;212;0.39;18.76;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
233;25934;Cytokines, Cellular and Molecular Therapy;journal;14660830, 13684736;0.421;Q2;27;0;50;0;47;50;0.19;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2000, 2002;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
234;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.418;Q2;93;96;334;3301;417;322;1.21;34.39;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
235;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.418;Q2;98;122;269;2487;345;222;1.39;20.39;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
236;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.418;Q2;91;55;278;2053;352;275;1.13;37.33;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
237;86329;Mutation Research - Mutation Research Genomics;journal;13835726, 18731341;0.415;Q2;20;0;19;0;24;19;1.36;0;Netherlands;Western Europe;Elsevier BV;1997-2001;"Toxicology (Q2); Genetics (Q4)"
238;20634;Journal of Texture Studies;journal;00224901, 17454603;0.413;Q2;57;34;100;914;78;100;0.55;26.88;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
239;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.411;Q2;42;46;128;604;76;128;0.69;13.13;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
240;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.408;Q3;75;0;155;0;227;150;0.66;0;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q3); Toxicology (Q3)"
241;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.407;Q3;109;98;453;4048;580;368;1.21;41.31;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
242;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.401;Q3;58;51;81;1818;234;77;3.79;35.65;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
243;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.399;Q3;76;354;735;6127;512;734;0.63;17.31;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
244;4400151608;ChemMedChem;journal;18607187, 18607179;0.395;Q2;106;174;414;3902;448;411;1.08;22.43;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3); Molecular Medicine (Q4)"
245;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.395;Q3;88;38;136;1943;160;131;1.2;51.13;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
246;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.387;Q3;98;208;650;4034;634;649;0.9;19.39;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
247;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.384;Q2;65;60;202;1433;183;200;0.83;23.88;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
248;20570;Chemotherapy;journal;00093157, 14219794;0.382;Q3;58;54;219;1516;282;213;1.31;28.07;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
249;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.381;Q2;91;224;577;6379;584;575;0.87;28.48;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
250;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.379;Q3;20;61;181;0;134;181;0.69;0;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
251;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.378;Q3;42;73;275;1849;202;242;0.64;25.33;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
252;25106;Human and Experimental Toxicology;journal;09603271;0.373;Q3;82;100;331;2771;344;312;0.96;27.71;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
253;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.372;Q3;56;31;59;1850;66;57;1.12;59.68;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q3); Molecular Biology (Q4)"
254;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.367;Q3;77;76;171;3587;207;166;1.17;47.2;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
255;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.361;Q2;40;43;147;667;65;96;0.45;15.51;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
256;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.356;Q2;48;271;733;4858;385;732;0.53;17.93;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
257;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.345;Q3;38;31;38;1473;39;37;1.03;47.52;United States;Northern America;Old City Publishing;1996, 2002-2020;"Cancer Research (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
258;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.338;Q3;48;116;348;2128;265;347;0.9;18.34;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
259;130063;Pharmacological Reports;journal;17341140;0.338;Q3;87;131;232;4200;214;232;0.83;32.06;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
260;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.338;Q2;46;29;117;578;49;116;0.32;19.93;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
261;20026;BMC Clinical Pharmacology;journal;14726904;0.336;Q3;39;4;12;156;16;12;1.33;39;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
262;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.332;Q3;52;111;375;2964;400;346;1.09;26.7;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
263;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.332;Q3;50;31;104;1195;61;104;0.61;38.55;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
264;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.332;Q3;41;37;146;5044;91;98;0.47;136.32;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
265;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.331;Q3;70;71;178;2190;186;177;1.19;30.85;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
266;22375;Indian Drugs;journal;0019462X;0.326;Q2;31;119;413;1773;151;408;0.25;14.9;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
267;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.326;Q2;63;58;142;1233;131;124;0.84;21.26;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
268;18071;Neurotoxicity Research;journal;14763524, 10298428;0.325;Q3;78;56;108;3774;100;106;0.93;67.39;United States;Northern America;Springer New York;1999, 2001-2021;"Neuroscience (miscellaneous) (Q3); Toxicology (Q3)"
269;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.323;Q2;72;123;288;2727;142;287;0.49;22.17;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
270;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.322;Q3;52;44;0;2181;0;0;0;49.57;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
271;21717;Die Pharmazie;journal;00317144;0.322;Q2;66;242;690;5013;584;687;0.83;20.71;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
272;25144;Journal of Health Science;journal;13475207, 13449702;0.318;Q3;49;88;268;1760;211;268;0.66;20;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
273;37381;In Vitro and Molecular Toxicology: Journal of Basic and Applied Research;journal;10979336;0.316;Q3;21;0;53;0;41;46;0.83;0;United States;Northern America;Mary Ann Liebert Inc.;1996-2001;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
274;21100470510;Drug Research;journal;21949379, 21949387;0.312;Q3;65;127;463;2655;428;458;0.8;20.91;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
275;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.312;Q3;62;20;113;503;74;109;0.42;25.15;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
276;22365;International Antiviral News;journal;09652310;0.307;Q3;8;0;48;0;27;38;0.08;0;United Kingdom;Western Europe;International Medical Press Ltd;1994-2001;"Pharmacology (Q3); Virology (Q3)"
277;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.306;Q3;21;34;35;1482;11;34;0.31;43.59;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
278;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.303;Q3;93;185;361;3172;274;361;0.61;17.15;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
279;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.302;Q3;46;25;106;705;90;106;0.6;28.2;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
280;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.299;Q3;79;71;151;1890;142;150;0.87;26.62;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
281;26370;Molecules;journal;14203049;0.294;Q2;171;89;605;2632;286;601;0.65;29.57;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Physical and Theoretical Chemistry (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
282;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.292;Q2;69;49;65;1603;41;65;0.63;32.71;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
283;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.291;Q3;36;25;77;762;60;77;0.66;30.48;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Physiology (Q4)"
284;21127;Pharmaceutical Technology Europe;journal;01646826;0.289;Q2;18;78;256;429;41;148;0.2;5.5;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q2)
285;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.288;Q3;42;22;19;2881;13;17;0.68;130.95;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
286;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.288;Q3;48;30;79;588;65;69;1;19.6;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Biochemistry (Q4)"
287;23039;Journal of Liposome Research;journal;08982104, 15322394;0.287;Q2;53;24;96;453;68;88;0.59;18.88;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
288;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.287;Q2;50;19;84;471;45;82;0.47;24.79;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
289;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.284;Q2;66;31;128;925;83;122;0.44;29.84;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q4)"
290;25245;Veterinary and Human Toxicology;journal;01456296;0.284;Q3;41;100;317;1598;176;298;0.46;15.98;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Veterinary (miscellaneous) (Q3)"
291;4000148019;AAPS Journal;journal;15507416;0.28;Q2;118;58;228;1823;179;225;0.68;31.43;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q2)
292;29053;Molecular Diversity;journal;1573501X, 13811991;0.275;Q4;58;70;27;1930;24;26;0;27.57;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q2); Information Systems (Q3); Inorganic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Catalysis (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Organic Chemistry (Q4)"
293;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.274;Q3;53;52;143;1625;129;143;0.97;31.25;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
294;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0.27;Q3;16;14;34;463;25;28;0.74;33.07;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology (Q3)
295;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.269;Q3;61;52;239;1840;183;206;0.74;35.38;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
296;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.268;Q3;51;38;73;3673;57;69;0.5;96.66;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
297;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.268;Q3;51;81;206;1619;65;196;0.29;19.99;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
298;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.267;Q2;69;116;200;1587;115;200;0.55;13.68;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Education (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
299;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.265;Q3;19;24;158;324;49;110;0.33;13.5;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
300;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.261;Q2;50;57;213;766;55;206;0.28;13.44;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q4); Organic Chemistry (Q4)"
301;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.258;Q4;38;71;186;3035;89;185;0.45;42.75;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Bioengineering (Q3); Analytical Chemistry (Q4); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
302;20065;BioPharm International;trade journal;1542166X, 19391862;0.256;Q2;29;117;366;661;73;322;0.2;5.65;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
303;32946;Developments in Biological Standardization;journal;03015149;0.255;Q4;42;0;28;0;19;28;0;0;Switzerland;Western Europe;S. Karger AG;1974-2000;"Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Public Health, Environmental and Occupational Health (Q3); Drug Discovery (Q4)"
304;20578;Journal of Food and Drug Analysis;journal;10219498;0.255;Q3;63;53;119;1288;67;118;0.42;24.3;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
305;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.252;Q2;57;42;123;847;89;115;0.7;20.17;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
306;25253;Blutalkohol (discontinued);journal;00065250;0.252;Q3;13;21;89;317;25;87;0.23;15.1;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
307;23489;Chemical Speciation and Bioavailability;journal;09542299;0.252;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
308;24071;Metal-Based Drugs;journal;07930291, 16875486;0.25;Q3;38;0;107;0;79;106;0.63;0;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Inorganic Chemistry (Q3); Pharmacology (Q3); Toxicology (Q3); Drug Discovery (Q4)"
309;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.247;Q3;7;6;17;291;9;17;0.73;48.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
310;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.245;Q3;39;45;117;761;66;115;0.5;16.91;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
311;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.245;Q3;29;30;70;748;20;66;0.18;24.93;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
312;15340;Developments in Biologicals;journal;14246074, 16622960;0.242;Q3;38;50;239;286;146;239;0.34;5.72;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Biomaterials (Q3); Pharmacology (Q3); Immunology (Q4)"
313;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.242;Q3;39;27;176;814;122;175;0.43;30.15;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Molecular Medicine (Q4)"
314;73430;Pharmaceutical Technology;journal;15432521;0.238;Q2;38;143;341;903;123;306;0.36;6.31;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
315;25171;Mycotoxin Research;journal;18671632, 01787888;0.232;Q3;40;43;194;321;44;194;0.17;7.47;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Toxicology (Q3); Microbiology (Q4)"
316;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.231;Q3;62;69;203;2292;110;184;0.64;33.22;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
317;79053;Natural Product Sciences;journal;12263907;0.231;Q4;28;65;108;1310;43;108;0.32;20.15;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
318;23009;Journal of Clinical Research;journal;13695207;0.229;Q3;11;2;18;27;21;18;1.33;13.5;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
319;130089;Toxin Reviews;journal;15569543, 15569551;0.227;Q3;46;43;47;2070;40;41;0.77;48.14;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
320;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.225;Q2;45;84;288;1358;111;288;0.33;16.17;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
321;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;0.225;Q3;33;14;49;525;72;49;1.47;37.5;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
322;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.225;Q3;53;92;307;3899;192;307;0.59;42.38;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
323;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.223;Q2;20;40;100;612;34;85;0.3;15.3;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q2); Pharmaceutical Science (Q2)"
324;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.219;Q3;53;73;237;1690;102;187;0.29;23.15;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
325;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.219;Q2;31;18;44;387;37;44;0.85;21.5;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
326;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.219;Q3;19;11;33;191;9;33;0.24;17.36;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q1); Drug Guides (Q3); Pharmacology (Q3)"
327;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.215;Q2;9;48;104;589;27;90;0.26;12.27;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmaceutical Science (Q2); Pharmacy (Q2); Pharmacology (Q3)"
328;23055;Journal of Natural Toxins;journal;10588108;0.213;Q3;26;0;107;0;73;107;0.55;0;United States;Northern America;Alaken Inc.;1996-2002;"Environmental Science (miscellaneous) (Q3); Toxicology (Q3)"
329;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.212;Q2;43;106;341;3254;149;341;0.4;30.7;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
330;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.211;Q3;53;90;298;6018;178;296;0.75;66.87;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
331;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.209;Q2;14;32;116;836;18;116;0.11;26.13;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
332;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.207;Q2;19;220;606;846;58;599;0.12;3.85;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q2)
333;110097;Food and Drug Law Journal;journal;1064590X;0.206;Q3;22;40;100;539;26;99;0.32;13.48;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
334;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.206;Q3;29;46;143;920;39;141;0.16;20;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
335;21496;Revista de Chimie (discontinued);journal;00347752;0.206;-;31;223;472;2953;103;472;0.26;13.24;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
336;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.205;Q3;39;39;110;816;103;109;0.72;20.92;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
337;66652;Toxic Substance Mechanisms;journal;10769188;0.205;Q4;12;0;15;0;7;15;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2000;"Pollution (Q3); Toxicology (Q4)"
338;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.204;Q3;61;155;337;2811;86;336;0.22;18.14;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q3)
339;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.203;Q3;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Medicine (miscellaneous) (Q2); Clinical Psychology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
340;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.202;Q4;53;29;134;945;80;134;0.7;32.59;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q4)"
341;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.201;Q3;24;66;163;1097;35;130;0.16;16.62;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
342;19446;American Pharmaceutical Review;journal;10998012;0.2;Q3;24;71;71;795;30;62;0.42;11.2;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
343;13718;Pharmaceutical Engineering;journal;02738139;0.2;Q3;16;51;130;314;23;130;0.18;6.16;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
344;19374;AAPS PharmSciTech;journal;15309932;0.198;Q3;101;72;115;1405;66;109;0.59;19.51;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Medicine (miscellaneous) (Q2); Agronomy and Crop Science (Q3); Ecology (Q3); Pharmaceutical Science (Q3); Aquatic Science (Q4); Drug Discovery (Q4); Ecology, Evolution, Behavior and Systematics (Q4)"
345;18800156720;Dissolution Technologies;journal;1521298X;0.198;Q3;34;15;41;154;24;21;0.37;10.27;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q3)
346;21798;Farmaceutski Glasnik;journal;00148202;0.198;Q3;6;26;40;312;8;40;0.3;12;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
347;24097;Journal of the Indian Chemical Society;journal;00194522;0.198;Q4;33;238;607;5892;207;604;0.31;24.76;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
348;52649;Pharmaceutical and Pharmacological Letters;journal;09399488;0.194;Q3;17;0;51;0;18;50;0.37;0;Germany;Western Europe;Stuttgart Medpharm Scientific Publishers;1996-2001;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
349;22881;Yaoxue Xuebao;journal;05134870;0.193;Q2;34;229;675;2312;155;675;0.27;10.1;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
350;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.192;Q3;6;27;76;291;18;67;0.21;10.78;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
351;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.192;Q3;10;52;128;284;7;126;0.06;5.46;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
352;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.191;Q3;7;25;86;523;21;86;0.29;20.92;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
353;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.19;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
354;20783;Expert Review of Vaccines;journal;14760584, 17448395;0.19;Q3;91;78;57;5374;27;53;0.47;68.9;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Pharmacology (Q3); Drug Discovery (Q4); Immunology (Q4); Molecular Medicine (Q4)"
355;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q3;5;156;265;231;6;251;0.04;1.48;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
356;40278;Adverse Drug Reactions and Toxicological Reviews;journal;0964198X;0.186;Q3;24;0;65;0;45;41;0.63;0;United Kingdom;Western Europe;Adis International Ltd;1991-2002;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
357;22906;Journal of China Pharmaceutical University;journal;10005048;0.186;Q3;14;144;136;1340;22;136;0.16;9.31;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
358;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.186;Q3;19;16;48;413;17;41;0.35;25.81;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
359;17700156431;Handbook of Analytical Separations;book series;15677192;0.185;Q3;12;15;55;1162;23;47;0.17;77.47;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pathology and Forensic Medicine (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4)"
360;54408;Pharmacy and Pharmacology Communications;journal;14608081;0.185;Q3;25;0;102;0;57;102;0;0;United Kingdom;Western Europe;Pharmaceutical Press;1993, 1995, 1998-2000;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
361;24659;Comments on Toxicology;journal;08865140;0.184;Q4;12;12;47;466;12;41;0.26;38.83;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q4)
362;21102;Pharmaceutical Journal;journal;00316873;0.182;Q3;28;2523;4085;1159;161;612;0.03;0.46;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
363;21229;Drug News and Perspectives;journal;02140934;0.181;Q3;51;85;190;4052;72;190;0.38;47.67;Spain;Western Europe;Prous Science;1990-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
364;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.179;Q3;60;33;106;689;40;106;0.33;20.88;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
365;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.175;Q3;13;45;133;796;25;99;0.2;17.69;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
366;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.174;Q3;15;12;59;142;19;59;0.33;11.83;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q3); Physiology (Q4)"
367;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.174;Q4;48;0;70;0;33;70;0.62;0;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
368;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.173;Q3;20;32;89;540;13;89;0.16;16.88;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
369;16893;Biogenic Amines;journal;15693910, 01688561;0.171;Q3;15;28;73;1075;21;73;0.25;38.39;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Pharmacology (Q3); Neuroscience (miscellaneous) (Q4)"
370;35190;Revista Espanola de Quimioterapia;journal;02143429;0.165;Q3;26;58;133;2144;53;118;0.35;36.97;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
371;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;0.161;Q3;51;27;26;2956;7;26;0.27;109.48;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
372;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.161;Q3;9;40;94;701;6;80;0.06;17.53;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
373;72755;Phytomedica;journal;09723293;0.16;Q3;4;15;46;251;10;46;0.25;16.73;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
374;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.16;Q3;24;49;176;892;45;176;0.24;18.2;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
375;19484;Antibiotics and chemotherapy;journal;00664758, 16622863;0.156;Q3;8;0;18;0;7;18;0;0;Switzerland;Western Europe;S. Karger AG;1956, 1964-1965, 1968-1971, 1974-1976, 1978-1983, 1985, 1987-1989, 1991-1992, 1994-1996, 1998, 2000;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
376;21867;Geneesmiddelenbulletin;journal;03044629;0.156;Q3;7;68;250;176;18;38;0.07;2.59;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
377;34232;Toxicology Methods;journal;10517235;0.156;Q4;18;0;42;0;22;42;0.33;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2001;Toxicology (Q4)
378;19700180810;Alkaloids: Chemical and Biological Perspectives;book series;07358210;0.155;Q4;14;0;6;0;2;4;0.33;0;Netherlands;Western Europe;Elsevier;1996, 1998-1999, 2001;"Drug Discovery (Q4); Organic Chemistry (Q4)"
379;52550;Pharmacology and Toxicology, Supplement;journal;09019936;0.155;Q3;7;0;10;0;3;9;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1990-2000;"Pharmacology (Q3); Toxicology (Q4)"
380;21211;Pharmacy Education;journal;14772701, 15602214;0.155;Q3;18;34;36;570;13;34;0.36;16.76;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q2); Education (Q3); Pharmaceutical Science (Q3)"
381;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.152;Q4;62;77;246;1274;67;167;0.23;16.55;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
382;22411;Inflammopharmacology;journal;09254692, 15685608;0.152;Q4;55;44;88;1686;32;87;0.37;38.32;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (medical) (Q3); Immunology (Q4); Pharmacology (Q4)"
383;23171;Korean Journal of Pharmacognosy;journal;02533073;0.152;Q3;17;66;157;1264;21;157;0.1;19.15;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
384;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.152;Q4;46;35;23;1447;10;22;0.43;41.34;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
385;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.151;Q4;22;36;33;835;6;33;0.18;23.19;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
386;21264;Drugs in R and D;journal;11796901, 11745886;0.149;Q4;47;75;89;1026;36;71;0.4;13.68;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q4)
387;20564;Ceska a Slovenska Farmacie;journal;12107816;0.148;Q3;17;49;164;1643;56;161;0.4;33.53;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
388;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.145;Q3;13;53;159;822;27;91;0.19;15.51;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
389;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.143;Q4;12;88;274;1178;43;273;0.17;13.39;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
390;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.143;Q3;8;14;43;278;9;43;0.11;19.86;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
391;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.142;Q4;6;13;32;454;8;32;0.25;34.92;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q3); Pharmacology (Q4)"
392;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.141;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q2); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
393;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.141;Q3;19;26;107;626;15;91;0.18;24.08;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q4)"
394;18005;American Journal of Respiratory Medicine;journal;11756365;0.14;Q4;32;42;51;3646;14;45;0.27;86.81;United Kingdom;Western Europe;Adis International Ltd;2002-2003;"Pulmonary and Respiratory Medicine (Q3); Pharmacology (Q4)"
395;17716;Quality Assurance Journal;journal;10991786, 10878378;0.14;Q3;9;28;89;184;6;76;0.09;6.57;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
396;21142;Pharmaceutisch Weekblad;journal;00316911;0.139;Q4;9;501;1316;2522;126;957;0.12;5.03;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
397;22338;Hospital Pharmacy;journal;19451253, 00185787;0.138;Q4;24;150;496;1739;67;408;0.11;11.59;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (medical) (Q3); Pharmacology (Q4)"
398;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.138;Q3;8;17;49;1231;15;47;0;72.41;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biomedical Engineering (Q4); Biotechnology (Q4)"
399;26767;Altex;journal;1868596X, 18688551;0.136;Q4;57;40;106;375;23;95;0.27;9.38;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
400;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.136;Q3;43;86;121;1475;19;113;0.13;17.15;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
401;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.136;Q4;19;139;365;3244;67;335;0.22;23.34;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
402;20572;PZ Prisma;journal;09455566;0.136;Q3;5;30;99;726;5;87;0.02;24.2;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
403;75047;Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs;journal;14648474;0.135;Q4;5;0;35;0;9;30;0;0;United Kingdom;Western Europe;Current Drugs Ltd.;2000;"Immunology (Q4); Pharmacology (Q4)"
404;94084;Drug Discovery Today: TARGETS;journal;17418372;0.135;Q4;15;62;45;1308;14;38;0.31;21.1;Netherlands;Western Europe;Elsevier BV;2002-2004;Drug Discovery (Q4)
405;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.133;Q4;37;24;104;542;39;101;0.46;22.58;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
406;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.133;Q3;20;17;53;409;12;53;0.13;24.06;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
407;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.132;Q4;35;234;300;3665;60;300;0.17;15.66;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
408;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.131;Q3;27;55;179;1142;47;167;0.27;20.76;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
409;22887;Chinese Journal of Antibiotics;journal;10018689;0.131;Q4;11;200;419;1906;33;385;0.1;9.53;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
410;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.131;Q4;5;8;27;464;3;27;0.13;58;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
411;20543;Pharmacometrics;journal;03008533;0.13;Q3;6;24;47;406;10;47;0.14;16.92;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
412;79249;Modern Drug Discovery;journal;10998209;0.128;Q3;9;0;41;0;14;41;0.16;0;United States;Northern America;American Chemical Society;1998-2001;Pharmaceutical Science (Q3)
413;21758;Prescrire International;journal;11677422;0.128;Q4;13;177;298;1017;60;214;0.18;5.75;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
414;25196;Revista Brasileira de Toxicologia;journal;14152983;0.128;Q4;7;16;43;338;7;38;0.18;21.13;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
415;25197;Revista de Toxicologia (discontinued);journal;02127113;0.128;Q4;11;22;66;638;8;65;0.07;29;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
416;20661;Current Drug Discovery;journal;14727463;0.127;Q4;12;130;174;17;30;110;0.17;0.13;United Kingdom;Western Europe;Current Drugs Ltd.;2002-2004;Pharmacology (Q4)
417;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.127;Q4;39;14;99;342;12;99;0.21;24.43;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
418;68818;International Journal of Geriatric Psychopharmacology;journal;13648233;0.127;Q3;11;0;18;0;4;18;0;0;United Kingdom;Western Europe;Stockton Press;1997-2000;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Geriatrics and Gerontology (Q4); Neuropsychology and Physiological Psychology (Q4)"
419;19700180757;Advances in Phytomedicine;book series;1572557X;0.126;Q4;13;0;29;0;3;0;0.1;0;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
420;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.126;Q4;9;8;42;162;7;42;0.22;20.25;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
421;22934;Chinese Pharmaceutical Journal;journal;10012494;0.126;Q3;21;349;920;3877;64;920;0.05;11.11;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
422;22977;Journal de Pharmacie de Belgique;journal;00472166;0.126;Q3;12;17;72;302;7;72;0.09;17.76;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
423;19700175108;Drug Delivery System;journal;18812732, 09135006;0.125;Q4;8;32;95;627;8;95;0.03;19.59;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
424;22205;Saudi Pharmaceutical Journal;journal;13190164;0.125;Q3;57;25;79;791;6;76;0.09;31.64;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
425;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.124;Q4;29;31;64;500;15;60;0.23;16.13;United States;Northern America;The Haworth Herbal Press;2001-2008;"Biochemistry (Q4); Pharmacology (Q4)"
426;21077;Pharmaca;journal;00316857;0.124;Q4;5;3;27;128;3;27;0.14;42.67;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
427;62531;Pharmaceutical News;journal;1071894X;0.124;Q4;11;0;167;0;28;144;0.14;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2002;Pharmaceutical Science (Q4)
428;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.124;Q4;6;38;32;124;2;15;0.06;3.26;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
429;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.124;Q4;7;14;46;525;8;46;0.14;37.5;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
430;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.123;Q4;47;32;61;645;13;60;0.23;20.16;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
431;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.123;Q4;4;148;82;1136;7;82;0.1;7.68;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
432;22514;Japanese Journal of Chemotherapy;journal;13407007;0.123;Q4;12;92;221;1399;22;220;0.05;15.21;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
433;21716;Pharmazeutische Zeitung;journal;00317136;0.123;Q4;7;470;1295;1476;19;652;0.01;3.14;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
434;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.121;Q4;23;4;3;59;4;1;1.33;14.75;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Medicine (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
435;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.121;Q4;87;185;0;5647;0;0;0;30.52;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
436;130031;Journal of Toxicologic Pathology;journal;09149198;0.121;Q4;30;2;121;32;29;121;0.23;16;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
437;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.119;Q4;18;12;50;473;9;49;0.08;39.42;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
438;15842;Journal of Applied Research;journal;1537064X;0.118;Q4;22;65;39;1634;9;39;0.23;25.14;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
439;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.117;Q4;32;20;77;603;7;66;0.06;30.15;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
440;22908;Chinese Pharmacological Bulletin;journal;10011978;0.116;Q4;17;363;718;4492;51;718;0.06;12.37;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
441;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.116;Q4;21;11;28;465;5;10;0.18;42.27;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
442;94039;Journal of Managed Pharmaceutical Care;journal;15349721, 15349713;0.115;Q4;3;0;35;0;3;34;0.09;0;United States;Northern America;Pharmaceutical Products Press;2001;"Leadership and Management (Q3); Pharmacology (Q4)"
443;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.115;Q4;33;60;174;1732;13;174;0.08;28.87;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
444;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.114;Q4;6;31;119;192;16;119;0.1;6.19;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Medicine (miscellaneous) (Q3); Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
445;69108;Chemotherapie Journal, Supplement;journal;09446486;0.114;Q4;6;6;40;148;10;39;0.22;24.67;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
446;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.114;Q4;11;29;9;1149;2;9;0.22;39.62;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
447;54564;Antimicrobics and Infectious Diseases Newsletter;journal;1069417X;0.113;Q4;5;0;24;0;3;24;0;0;Netherlands;Western Europe;Elsevier BV;1994-1998, 2000, 2002;"Microbiology (medical) (Q4); Pharmacology (Q4)"
448;145693;Canadian Pharmacists Journal;journal;17151635;0.113;Q4;24;121;360;624;13;258;0.04;5.16;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
449;22979;Journal of Applied Therapeutic Research;journal;10292659;0.113;Q4;8;18;8;301;1;8;0;16.72;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
450;16117;Pharmaceutical Biotechnology;journal;10780467;0.113;Q4;27;0;16;0;6;16;0.38;0;United States;Northern America;Kluwer/Plenum Publishers;1993, 1995-1999, 2002;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
451;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.113;Q4;13;72;189;832;19;165;0.08;11.56;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
452;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.111;Q4;6;25;47;413;1;47;0.03;16.52;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
453;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.11;Q4;7;53;200;659;4;200;0.04;12.43;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
454;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.11;Q4;16;95;388;1798;7;387;0.02;18.93;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
455;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.11;Q4;14;23;59;156;14;59;0.2;6.78;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
456;21227;Pharmacy in Practice;journal;13581538;0.108;Q4;5;51;67;412;5;52;0.07;8.08;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Pharmacy (Q3); Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
457;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.108;Q4;32;269;514;2138;33;514;0.07;7.95;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
458;21238;Drug Topics;journal;19378157, 00126616;0.107;Q4;8;461;1090;4;37;781;0.03;0.01;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
459;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.107;Q4;65;41;22;946;3;21;0.14;23.07;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Bioengineering (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Computer Science Applications (Q4); Electrical and Electronic Engineering (Q4); Medicine (miscellaneous) (Q4); Nanoscience and Nanotechnology (Q4); Pharmaceutical Science (Q4)"
460;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.107;-;31;57;68;906;6;64;0.03;15.89;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
461;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.107;Q4;34;171;551;2711;20;549;0.03;15.85;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
462;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.106;Q4;10;16;23;476;0;22;0;29.75;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
463;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.106;Q4;35;75;90;1381;1;82;0.01;18.41;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
464;13637;Manufacturing Chemist;trade journal;02624230;0.106;Q4;6;0;1433;0;2;58;0;0;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
465;19700180737;Pharmacochemistry Library;journal;01657208;0.106;Q4;10;0;48;0;4;44;0.16;0;Netherlands;Western Europe;Elsevier;1995-1998, 2000, 2002;"Drug Discovery (Q4); Organic Chemistry (Q4); Pharmacology (Q4)"
466;19407;Acta Poloniae Toxicologica;journal;12306967;0.105;Q4;4;0;67;0;11;67;0.15;0;Poland;Eastern Europe;Polskie Towarzystwo Toksykologiczne/Polish Society of Toxicology;1999-2002;Toxicology (Q4)
467;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.105;Q4;2;1;4;64;0;4;0;64;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
468;79257;Antiinfective Drugs and Chemotherapy;journal;09464832;0.105;Q4;6;0;4;0;0;4;0;0;Germany;Western Europe;Futuramed Publishers Gmbh;1994-1998, 2000;Pharmacology (Q4)
469;88338;Journal of Pharmacoepidemiology;journal;08966966;0.105;Q4;4;0;4;0;0;4;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";1991, 1994-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
470;21813;Research Communications in Alcohol and Substances of Abuse;journal;10808388;0.105;Q4;5;0;4;0;0;4;0;0;United States;Northern America;PJD Publications Ltd;1994-1999, 2001;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
471;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.104;Q4;28;19;112;0;5;112;0.04;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
472;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.104;Q4;15;109;419;2175;16;419;0.03;19.95;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
473;91481;Pharmacology Reviews and Communications;journal;10288945;0.104;Q4;9;0;60;0;8;60;0.14;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2002;Pharmacology (Q4)
474;37682;Gyogyszereszet;journal;00176036;0.103;Q4;2;0;6;0;0;6;0;0;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1960-1962, 1973-1985, 1988-2000;Pharmacology (Q4)
475;23169;Klinische Pharmakologie Aktuell;journal;09395164;0.103;Q4;3;0;12;0;0;6;0;0;Germany;Western Europe;W.Zuckschwerdt Verlag GmbH;1995-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
476;63556;Pharmacie Hospitaliere Francaise;journal;03699579;0.103;Q4;4;0;6;0;0;6;0;0;France;Western Europe;Syndicat des Pharmaciens Gerants;1982-2000;Pharmaceutical Science (Q4)
477;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.102;Q4;11;14;43;136;1;31;0;9.71;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
478;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.102;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
479;59522;Current Therapeutics;journal;0311905X;0.102;Q4;5;0;358;0;9;281;0.03;0;Australia;Pacific Region;ADIS Press;1974-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
480;21329;European Journal of Herbal Medicine;journal;13524755;0.102;Q4;2;3;20;20;2;12;0.1;6.67;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology (Q4)
481;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.102;Q4;9;8;11;0;0;11;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
482;21837;Revista Portuguesa de Farmacia;journal;0484811X;0.102;Q4;5;0;39;0;2;39;0.05;0;Portugal;Western Europe;Ordem dos Farmaceuticos;1961, 1990-2001;Pharmaceutical Science (Q4)
483;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.101;Q4;11;22;24;695;1;24;0;31.59;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
484;72763;Drugs Made in Germany;journal;00126683;0.101;Q4;4;0;37;0;1;36;0.03;0;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1964, 1973-2002;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
485;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;0;25;0;0;24;0;0;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
486;97159;Journal of Research in Pharmaceutical Economics;journal;08966621;0.101;Q4;5;0;36;0;2;29;0.07;0;United States;Northern America;Pharmaceutical Products Press;1996-1998, 2000-2001;"Health Policy (Q4); Pharmaceutical Science (Q4)"
487;21823;Pharmacia;journal;04280296;0.101;Q4;16;13;34;293;0;32;0;22.54;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
488;58672;Prescribers' Journal;journal;00327611;0.101;Q4;6;0;29;0;0;23;0;0;United Kingdom;Western Europe;Her Majesty's Stationery Office;1970, 1973-2000;Pharmaceutical Science (Q4)
489;21826;Revista Brasileira de Farmacia;journal;0370372X;0.101;Q4;9;0;13;0;0;13;0;0;Brazil;Latin America;Associacao Brasileira De Farmaceuticos;1945, 1984-2000;Pharmaceutical Science (Q4)
490;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.101;Q4;9;0;24;0;0;24;0;0;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
491;36238;Therapiewoche Schweiz;journal;02566869;0.101;Q4;1;0;15;0;0;15;0;0;Switzerland;Western Europe;Therapiewoche Verlag;1990-2000;Pharmacology (Q4)
492;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;40;101;143;0;90;0;3.58;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
493;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.1;Q4;17;52;64;997;0;64;0;19.17;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
494;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.1;Q4;34;14;71;0;1;71;0.01;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
495;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;104;95;312;4;62;0.04;3;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
496;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;5;10;39;590;0;39;0;59;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
497;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;13;43;151;0;40;0;11.62;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
498;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;29;80;444;0;76;0;15.31;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
499;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.1;Q4;9;4;55;0;1;54;0.02;0;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
500;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.1;Q4;5;20;47;476;0;47;0;23.8;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
501;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.1;Q4;10;0;39;0;1;39;0.03;0;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
502;63560;Pharmaceutical Visions;journal;09661719;0.1;Q4;1;0;68;0;0;54;0;0;United Kingdom;Western Europe;London Monarch Communications;1997-2001;Pharmaceutical Science (Q4)
503;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.1;Q4;14;0;64;0;0;64;0;0;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
504;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.1;Q4;18;13;37;301;0;37;0;23.15;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
505;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;6;52;154;3514;3;154;0.02;67.58;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
506;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;93;677;1438;224;663;0.34;15.46;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
507;9500153934;Therapiewoche;journal;02566869;0.1;Q4;1;0;94;0;0;81;0;0;Austria;Western Europe;Therapiewoche Verlag;2000-2002;Pharmacology (Q4)
508;86688;Acta Toxicologica;journal;17316383;;-;7;17;0;426;0;0;0;25.06;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology
509;12000154522;Advances in Antiviral Drug Design;book series;10758593;;-;12;7;0;619;0;0;0;88.43;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Infectious Diseases; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Virology"
510;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;;-;40;20;0;1615;0;0;0;80.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine; Hematology; Medicine (miscellaneous); Pharmacology"
511;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;;-;12;5;0;92;0;0;0;18.4;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary
512;23155;Current Vascular Pharmacology;journal;15701611, 18756212;;-;63;33;0;3801;0;0;0;115.18;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine; Pharmacology"
513;62892;Drug Discovery Today: BIOSILICO;journal;17418364;;-;17;36;0;584;0;0;0;16.22;Netherlands;Western Europe;Elsevier BV;2003-2004;Drug Discovery
514;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;13;36;407;21;36;0.48;31.31;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
515;21810;Farmacia;journal;00148237;;-;27;1;0;3;0;0;0;3;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
516;145164;Human Genomics;journal;14739542, 14797364;;-;59;7;0;20;0;0;0;2.86;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery; Genetics; Molecular Biology; Molecular Medicine"
517;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;51;12;804;2;12;0.17;15.76;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
518;15892;Journal of Drug Evaluation;journal;14791137;;-;4;21;0;1019;0;0;0;48.52;United Kingdom;Western Europe;Parthenon Publishing Group;2003-2004;"Pharmacology; Pharmacy"
519;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;29;51;287;9;51;0.21;9.9;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
520;144613;Journal of Generic Medicines (discontinued);journal;17411343;;-;15;11;0;81;0;0;0;7.36;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science
521;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;;-;21;5;0;135;0;0;0;27;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Immunology; Pharmacology"
522;21281;Journal of Immunotherapy;journal;10538550;;-;46;20;126;676;342;125;3.18;33.8;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2004;"Cancer Research; Immunology; Pharmacology"
523;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;;-;66;101;0;671;0;0;0;6.64;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy; Pharmaceutical Science; Pharmacy"
524;16088;Journal of Nanobiotechnology;journal;14773155;;-;84;6;0;167;0;0;0;27.83;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology; Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Molecular Medicine; Nanoscience and Nanotechnology; Pharmaceutical Science"
525;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;;-;7;20;0;394;0;0;0;19.7;United States;Northern America;Haworth Press Inc.;2003-2008;"Health Policy; Pharmaceutical Science; Pharmacology"
526;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;64;124;1343;23;123;0.18;20.98;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
527;144790;Marine Drugs;journal;16603397;;-;128;8;0;145;0;0;0;18.13;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;"Drug Discovery; Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
528;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;1;96;0;38;91;0.43;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
529;34348;Teratogenesis Carcinogenesis and Mutagenesis;journal;02703211;;-;40;42;125;980;127;121;0.93;23.33;United States;Northern America;"John Wiley &amp; Sons Inc.";1980-2003;"Genetics; Genetics (clinical); Health, Toxicology and Mutagenesis; Oncology; Toxicology"
530;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;;-;43;27;0;1457;0;0;0;53.96;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases; Pharmacology; Pharmacology (medical); Virology"
531;22318;Toxicological Reviews;journal;11762551;;-;46;23;0;1905;0;0;0;82.83;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology; Toxicology"
